Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
نویسندگان
چکیده
The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier second trimesters of pregnancy, but its use beyond 24 weeks' gestation is less well described. This document attempts to synthesize the existing evidence for the use of misoprostol with or without mifepristone to induce labor for nonviable pregnancies at gestations of 24-28 weeks. The composite evidence suggests that a regimen combining mifepristone and misoprostol may shorten the time to expulsion, though the overall success rates are similar to those seen with misoprostol-only regimens.
منابع مشابه
Interruption of nonviable pregnancies of 24–28 weeks' gestation using medical methods
The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier seco...
متن کاملI-44: Increased Nuchal Translucency at 11-14 Weeks of Gestation As A Marker for Adverse Pregnancy Outcomes
Background: To evaluate the association of increased fetal nuchal translucency( NT) and adverse pregnancy outcomes. Materials and Methods: In a prospective study, 2221 women who were conceived after Assisted Conception were investigated by sonography independent of multiplicity between 11 and 13 weeks' gestation. We performed 2899 NT examinations during the study period(21 March 2010 to 21...
متن کاملبررسی ارتباط لیپدهای خون زنان باردار در هفتههای 13 تا 23 بر مختل شدن تست رقابت گلوکز
Background and Objective: Gestational diabetes mellitus (GDM) complicates 3-5% of all pregnancies. Glucose Challenge Test (GCT) is a universal screening test for GDM between 24-28 of gestation. Plasma glucose is measured 1 hr after ingestion of 50g glucose load. The aim of this study was to determine the relationship of plasma lipids in 13-23 weeks of pregnancy with abnormal GCT (Glucose Challe...
متن کاملComparison of First Trimester Screening for Down’s Syndrome Using Free Beta-Human Chorionic Gonado-tropin and Pregnancy-Associated Plasma Protein-A Levels between Spontaneous and IVF Pregnancies at 12 Weeks of Gestation
Objective The purpose of this study was to compare Free Beta-HCG and PAPPA levels in single normal and under IVF pregnancies 11-13w + 6d of gestational age. MaterialsAndMethods In this observational study that was performed as a cohort, 300 consecutive single IVF pregnancies and 700 single normal pregnancies were enrolled about 11-13w + 6d of gestational age and Free Beta-HCG and PAPPA was comp...
متن کاملسونوگرافی در تعیین سن حاملگی در سه ماه اول و کاهش میزان حاملگی از موعد گذشته
Background: Approximately 10 percent of all pregnancies continue to 42 weeks'gestation. The true prevalence of pregnancies lasting longer than 41 or 42 weeks'gestation has been difficult to establish because many such diagnoses occur as a result of an inability to accurately establish time of conception. Several studies indicate that menstrual dating is often inaccurate and can lead to inductio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Contraception
دوره 88 3 شماره
صفحات -
تاریخ انتشار 2013